The FDA has refused to review Moderna's flu vaccine. The decision may raise concerns about the agency's stance on vaccines and drug approvals in general. The article does not provide further details about the reasons for rejection or statistics. This is a report focused on the position of the US Food and Drug Administration (FDA). No other facts about the vaccine or the study are given in the content.